Literature DB >> 29621695

Incidence of isolated local breast cancer recurrence and contralateral breast cancer: A systematic review.

Inge Spronk1, François G Schellevis2, Jako S Burgers3, Geertruida H de Bock4, Joke C Korevaar5.   

Abstract

An increasing number of women is surviving breast cancer and due to that at risk of developing an isolated ipsilateral breast tumor recurrence (IBTR) or a contralateral breast cancer (CBC). Patients' main concern is cancer recurrence. Patient counseling on breast cancer recurrence is challenging. In order to provide healthcare professionals and patients more guidance, a systematic literature review of the incidence of isolated IBTR and CBC in women diagnosed with early invasive breast cancer was performed. Medline, EMBASE and the Cochrane Library were searched from 2000 until October 2015. Multicenter studies reporting an IBTR or CBC rate in curatively treated adult females diagnosed with invasive breast cancer were included. The initial search yielded 6998 potentially relevant articles. Twenty were eligible for inclusion, representing 25 recurrence incidence rates. Both isolated IBTR and CBC incidence rates steadily increased with the length of follow-up, indicating that IBTR and CBC occur even more than 15 years after diagnosis. The annual incidence rate of isolated IBTR and CBC in women diagnosed with an early invasive breast cancer was 0.6% (range: 0.4-1.1%) and 0.5% (range: 0.2-0.7%), respectively. Analyzed data were lacking information about important risk factors and given treatment with regard to the incidence of recurrence, which hampers the prediction of patient tailored recurrence risks. The presented rates are therefore the best available estimates of isolated IBTR and CBC annual incidence rates based on the current literature. Healthcare professionals could use these rates in their communication with patients diagnosed with early invasive breast cancer.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast carcinoma; Contralateral breast cancer; Incidence rate; Ipsilateral breast tumor recurrence; Recurrence

Mesh:

Year:  2018        PMID: 29621695     DOI: 10.1016/j.breast.2018.03.011

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  21 in total

1.  Chemotherapy for ipsilateral breast tumor recurrence: a propensity score-matching study.

Authors:  Soo Yeon Baek; Jisun Kim; Il Yong Chung; Beom Seok Ko; Hee Jeong Kim; Jong Won Lee; Byung Ho Son; Sei-Hyun Ahn; Sae Byul Lee
Journal:  Breast Cancer Res Treat       Date:  2022-01-30       Impact factor: 4.872

2.  Prevention of Late Recurrence: An Increasingly Important Target for Breast Cancer Research and Control.

Authors:  Serban Negoita; Esmeralda Ramirez-Pena
Journal:  J Natl Cancer Inst       Date:  2022-03-08       Impact factor: 13.506

3.  The relationships between fear of cancer recurrence, spiritual well-being and psychological resilience in non-metastatic breast cancer survivors during the COVID-19 outbreak.

Authors:  Lokman Koral; Yalcin Cirak
Journal:  Psychooncology       Date:  2021-06-09       Impact factor: 3.955

4.  Usefulness of postoperative serum translocator protein as a predictive marker for delirium after breast cancer surgery in elderly women.

Authors:  Guo-Wen Lu; Yi-Er Chou; Wan-Ling Jin; Xiao-Bao Su
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

5.  Incidence and Predictors of Recurrence among Breast Cancer Patients in Black Lion Specialized Hospital Adult Oncology Unit, Addis Ababa, Ethiopia: Retrospective Follow-up Study with Survival Analysis.

Authors:  Wondimeneh Shibabaw Shiferaw; Yared Asmare Aynalem; Tadesse Yirga Akalu; Tefera Mulugeta Demelew
Journal:  J Cancer Prev       Date:  2020-06-30

6.  Effect of LINC00657 on Apoptosis of Breast Cancer Cells by Regulating miR-590-3p.

Authors:  Qiuli Shan; Fan Qu; Weiping Yang; Ningning Chen
Journal:  Cancer Manag Res       Date:  2020-06-15       Impact factor: 3.989

7.  The risk of contralateral breast cancer: a SEER-based analysis.

Authors:  Vasily Giannakeas; David W Lim; Steven A Narod
Journal:  Br J Cancer       Date:  2021-05-26       Impact factor: 9.075

8.  Long non-coding RNA SATB2-AS1 inhibits microRNA-155-3p to suppress breast cancer cell growth by promoting breast cancer metastasis suppressor 1-like.

Authors:  Shaoqiang Cheng; Bingshu Xia; Hongbin Li; Yuying Li; Xinxin Lv; Yue Zhang; Yuanxi Huang
Journal:  Cancer Cell Int       Date:  2020-07-17       Impact factor: 5.722

9.  Participation in breast cancer screening among breast cancer survivors -A nationwide register-based cohort study.

Authors:  Mette Bach Larsen; Ilse Vejborg; Sisse Helle Njor
Journal:  Breast       Date:  2020-08-30       Impact factor: 4.380

10.  Concomitant fulvestrant with reirradiation for unresectable locoregional recurrent estrogen receptor positive (ER+) breast cancer: A case report and narrative review.

Authors:  Jingxian Ding; Yonghong Guo; Xiaoliu Jiang; Kai Li; Wenbing Fu; Yali Cao
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.